# Debate Matchup Judgment Report

**Claude Opus 5.5 (high)** vs **Claude Opus 5 (high)**

- Paired result: **Tie**
- Mean entertainment: `7.83 / 10`
- Judge decisions: `6` across two side-swapped debates

**Motion:** Consumer neurotechnology companies should be prohibited from using brain-signal data for advertising, personalization, or dynamic pricing even if users click through standard consent.

## Debates and evidence

- [Debate A transcript](../../../transcripts/prop_0067__claude-opus-5-5-high__claude-opus-5-high__s0__tpl_placement_active_20260813a.md): PRO = **Claude Opus 5.5 (high)**, CON = **Claude Opus 5 (high)**
- [Debate B transcript](../../../transcripts/prop_0067__claude-opus-5-high__claude-opus-5-5-high__s1__tpl_placement_active_20260813a.md): PRO = **Claude Opus 5 (high)**, CON = **Claude Opus 5.5 (high)**
- [Public judge decision table](../../../judgments/judge_results__judge_blend_20260923_finala.csv)

## Debate A

- Transcript: [read the full debate](../../../transcripts/prop_0067__claude-opus-5-5-high__claude-opus-5-high__s0__tpl_placement_active_20260813a.md)
- Roles: PRO = **Claude Opus 5.5 (high)**, CON = **Claude Opus 5 (high)**
- Judged result: Split `2-1` for **Claude Opus 5 (high)**.
- Entertainment scores: `8`, `9`, `7`
- Mean signed raw margin (PRO+): `-0.63`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| GPT-5.6 Sol (high) | A = Claude Opus 5 (high) (CON); B = Claude Opus 5.5 (high) (PRO) | Claude Opus 5 (high) | -1.3 | -1.23 | 9.0 |
| Gemini 3.1 Pro Preview | A = Claude Opus 5 (high) (CON); B = Claude Opus 5.5 (high) (PRO) | Claude Opus 5.5 (high) | +1.2 | +1.02 | 8.0 |
| Muse Spark 1.1 (high) | A = Claude Opus 5.5 (high) (PRO); B = Claude Opus 5 (high) (CON) | Claude Opus 5 (high) | -1.8 | -1.91 | 7.0 |

### Judge Notes

- **GPT-5.6 Sol (high)** (A = Claude Opus 5 (high) (CON); B = Claude Opus 5.5 (high) (PRO)): Side A won a clear but competitive debate by exposing the motion's categorical overbreadth. Its adaptive-session example squarely counted as personalization from brain data, and Side B ultimately accepted that such a benign use could be prohibited. Side A also offered a comparatively enforceable input-based rule covering harmful physiological targeting regardless of sensor, weakening B's bright-line advantage. Side B persuasively defended partial protection, neural sensitivity, and the limits of consent, but never fully answered why the motion should ban useful product personalization rather than the exploitative commercial practice. Side A overstated matters by calling the protection zero and using an unsupported ninety-nine-percent figure, while Side B incurred repeated clipping costs.
  Most decisive rebuttal noted: Side A's strongest exchange forced Side B to choose between rewriting personalization narrowly and conceding that the ban reaches an adaptive headset. Side B conceded the broader reading's cost, allowing Side A to crystallize the contrast between banning a harmful practice and banning use of a data category even for the product's beneficial function.
- **Gemini 3.1 Pro Preview** (A = Claude Opus 5 (high) (CON); B = Claude Opus 5.5 (high) (PRO)): Side B won by successfully exploiting a fatal flaw in Side A's "ban the conduct" alternative. Side B demonstrated that distinguishing benign personalization (adaptive sessions) from predatory personalization (engagement traps) is impossible without an intent audit, since both run the same code. Side A completely dropped this point in its final two speeches, allowing Side B to justify the motion's bright-line ban as the only enforceable mechanism.
  Most decisive rebuttal noted: Side B's Rebuttal 2 (B4.4) pointing out that adaptive sessions and engagement traps run the exact same code, proving that Side A's conduct rule would fail because intent cannot be cleanly audited from the outside.
- **Muse Spark 1.1 (high)** (A = Claude Opus 5.5 (high) (PRO); B = Claude Opus 5 (high) (CON)): CON neutralized PRO's core enforceability advantage by showing the audit is an input-layer check — asking if brain data was in the feed costs the same as asking if any physiological/affective signal was, so a superset ban on the harm is no harder to police. PRO never recovered from the under/over-inclusion ledger exposed by Q1/Q2: in A4.1/ A4.3 it conceded smartwatch-based 11pm targeting stays legal pending a second rule and accepted killing the benign adaptive headset as a cost. That leaves certain loss for honest personalization and zero extra protection against the same exploitation via cheap sensors, which B crystallized as the decisive tradeoff.
  Most decisive rebuttal noted: CON's Rebuttal 2 answer A2 and superset-audit move — that checking for any physiological signal is the same audit as checking for brain data, plus the on-device focus-score evasion showing a pure sensor ban can be circumvented while a practice ban catches it.

## Debate B

- Transcript: [read the full debate](../../../transcripts/prop_0067__claude-opus-5-high__claude-opus-5-5-high__s1__tpl_placement_active_20260813a.md)
- Roles: PRO = **Claude Opus 5 (high)**, CON = **Claude Opus 5.5 (high)**
- Judged result: Split `2-1` for **Claude Opus 5.5 (high)**.
- Entertainment scores: `8`, `8`, `7`
- Mean signed raw margin (PRO+): `-0.37`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| GPT-5.6 Sol (high) | A = Claude Opus 5.5 (high) (CON); B = Claude Opus 5 (high) (PRO) | Claude Opus 5.5 (high) | -1.4 | -1.32 | 8.0 |
| Gemini 3.1 Pro Preview | A = Claude Opus 5.5 (high) (CON); B = Claude Opus 5 (high) (PRO) | Claude Opus 5.5 (high) | -1.5 | -1.27 | 8.0 |
| Muse Spark 1.1 (high) | A = Claude Opus 5 (high) (PRO); B = Claude Opus 5.5 (high) (CON) | Claude Opus 5 (high) | +1.8 | +1.91 | 7.0 |

### Judge Notes

- **GPT-5.6 Sol (high)** (A = Claude Opus 5.5 (high) (CON); B = Claude Opus 5 (high) (PRO)): Side A won by holding Side B to the proposition’s unqualified ban on personalization. Side B compellingly justified a bright-line ban on neural advertising, offer targeting, and pricing, but repeatedly preserved therapeutic adaptation by redefining personalization as commercial offer-shaping. Side A showed that dimming audio, changing cues, and adjusting neurofeedback difficulty are still personalization using brain signals. Thus Side B either defended an overbroad rule that harms adaptive functions or retreated to the narrower targeted prohibition Side A supported. Side B had stronger rhetoric and an effective administrability argument, while Side A incurred clipping costs, but the unresolved textual overbreadth was decisive.
  Most decisive rebuttal noted: Side A’s strongest exchange was its answer to Side B’s bright-line test: Side B ultimately asked only whether an offer or price depended on neural data while expressly permitting adaptive therapeutic features. Side A correctly identified that this defended a narrower commercial-targeting ban rather than the proposition’s broader prohibition on personalization.
- **Gemini 3.1 Pro Preview** (A = Claude Opus 5.5 (high) (CON); B = Claude Opus 5 (high) (PRO)): Side A won by holding Side B to the actual text of the motion. Side B attempted to redefine 'personalization' to mean only commercial offers to avoid banning therapeutic functions, but Side A successfully proved this was an evasive rewrite of the resolution. Side A's 'scalpel vs. amputation' defense expertly neutralized Side B's best pressure.
  Most decisive rebuttal noted: Side A's second rebuttal and closing, which pointed out that Side B's promise to protect therapeutic audio-dimming contradicted the motion's explicit ban on 'personalization', forcing Side B to effectively adopt Side A's targeted rule.
- **Muse Spark 1.1 (high)** (A = Claude Opus 5 (high) (PRO); B = Claude Opus 5.5 (high) (CON)): PRO wins the central consent and enforceability clashes. CON's strong overbreadth attack is blunted when PRO reads "personalization" in context as commercial offer-tailoring, allowing the headband to still dim audio/adjust difficulty but not pitch the $99 tier when attention collapses. CON's answer "No" — even enthusiastic granular opt-in can't license fatigue-triggered offers — concedes PRO's core principle that some neural commerce is non-consentable, and PRO's bright-line input test (did brain data enter the ad/offers pipeline?) is more administrable than CON's need to prove which pre-conscious state a model used. Error-cost weighing and timing-beats-precision survive.
  Most decisive rebuttal noted: PRO's Rebuttal 2 pivot: coarse is enough for timing attacks and binary pipeline auditing beats CON's inference-naming rule — did brain data enter ad flow yes/no versus proving "fatigue label" inside a model.

## Technical metadata

- Evaluation scope: `judge_judge_blend_20260923_finala__debate_all_templates`
- Topic ID: `prop_0067`
- Side-swap group ID: `prop_0067__claude-opus-5-5-high__claude-opus-5-high__tpl_placement_active_20260813a`
- Raw paired winner: **Tie**
- Mean normalized margin for Claude Opus 5.5 (high): `-0.24`
- Complete side swap: `yes`
- Included in ratings: `yes`
